Skip to main content
Fig. 2 | Translational Medicine Communications

Fig. 2

From: Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020

Fig. 2

Flow cytometry gating strategy. Legend: Immunophenotype characterization of peripheral blood non-hematopoietic enriched stem cell cocktail. 2A) Logic and manual gating strategy for cell characterization using five monoclonal antibody-conjugated CD markers simultaneously, including 7-Amino-Actinomycin D (7-AAD). 2B) Expression of angiotensin-converting enzyme 2 (ACE2)

Back to article page